Skip to main content
Signal8

BriaCell Therapeutics Corp. (BCTX) Form 8-K — Jun 2, 2026

$BCTXForm 8-KItems 1.01, 3.02, 8.01, 9.01Filed Jun 2, 2026, 9:32 PM ET0001493152-26-026953Original filing

BriaCell Therapeutics Corp. (BCTX) announced the closing of a best-efforts private placement offering on June 2, 2026. The company sold 1,449,300 common shares at a price of $3.25 per share, generating gross proceeds of approximately $4.71 million. The offering was conducted pursuant to an existing shelf registration statement (Form S-3) filed in January 2024.

Key figures

Gross Proceeds
4710225
Offering Price
3.25
Shares Offered
1449300
Warrant Exercise Price
4.0625
Placement Agent Warrants
72465
Placement Agent Fee Percent
7.5

Price after filing

1 day: +1.2%7 days: -6.1%30 days: +6.1%

Close on the filing date to close N calendar days later (from $3.27). Historical, not a forecast.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.